Pediatric Infectious Diseases & Immunization
Session Overview
Pediatric infectious diseases and immunization constitute a cornerstone of child health, dedicated to preventing, diagnosing, and managing infections from the neonatal period through adolescence. This dynamic field sits at the intersection of immunology, epidemiology, and public health, grappling with both enduring challenges like antimicrobial resistance and novel threats from emerging pathogens. This session brings together clinical, scientific, and global health perspectives to examine advances in vaccine development, strategies to optimize immunization coverage, and the evolving landscape of infectious diseases affecting children worldwide.
Why This Session Matters Now
The recent pandemic has vividly underscored the critical importance of pediatric infectious disease preparedness and robust immunization systems. Concurrently, the rise of vaccine hesitancy, the persistent threat of antimicrobial resistance, and the emergence of novel pathogens demand agile and evidence-based responses. This session addresses the urgent need to integrate cutting-edge vaccine science with effective public health implementation, ensuring that scientific breakthroughs translate into equitable protection for all children against a shifting array of infectious threats.
Key Scientific and Clinical Themes
Pediatric Vaccine Science & Immunology
Examination of the latest advances in vaccine platforms, adjuvants, and immunization schedules, with a focus on understanding developmental immunology to optimize safety and efficacy from infancy through adolescence.
Childhood Immunization Programs, Coverage & Hesitancy
Analysis of strategies to achieve and sustain high vaccination coverage, including program delivery innovations, communication science to address hesitancy, and monitoring of vaccine impact on disease epidemiology.
Emerging & Re-emerging Pediatric Infectious Diseases
Discussion of the recognition, management, and containment of new and resurgent infectious threats, including novel viral pathogens, with an emphasis on pediatric-specific presentations and outbreak response.
Pediatric Respiratory & Viral Infections
Focus on the burden, pathogenesis, and evolving management of common and severe respiratory infections, including influenza, RSV, and post-viral complications, reflecting a leading cause of global childhood morbidity.
Tuberculosis, Antimicrobial Resistance & Stewardship
Exploration of the unique challenges in diagnosing and treating tuberculosis in children, alongside hospital and community-based strategies to promote antimicrobial stewardship and combat the growing crisis of resistance.
Nature of Research in This Field
Research in pediatric infectious diseases is highly translational and global in scope. It is characterized by large-scale phase III and IV vaccine trials, robust epidemiological surveillance, and implementation science studies. The field requires close collaboration between basic immunologists, clinical trial networks, and public health agencies to move discoveries from the bench to national immunization policies. Ethical considerations in conducting research in vulnerable pediatric populations are paramount and shape study design.
Who Should Attend
This session is designed for:
- Pediatric infectious disease specialists, immunologists, and virologists
- General pediatricians and family medicine physicians
- Public health professionals and epidemiologists in immunization programs
- Vaccine researchers and scientists in pharmaceutical and biotech industries
- Global health practitioners and advocates for child health equity
Session Perspective
The protection of children from infection is a fundamental measure of a society’s public health strength. This session provides a platform to connect the molecular science of pathogen and immune response with the practical realities of delivering protection at scale. By bridging discovery, policy, and community trust, the discussion aims to advance strategies that not only react to outbreaks but also build resilient, proactive defenses to safeguard child health across all populations.
If your research aligns with this session, we invite you to submit an abstract for consideration.
